Rearrangement of 2-Azabicyclo[2.2.0]hex-5-enes
J . Org. Chem., Vol. 66, No. 5, 2001 1809
removal of solvent in vacuo, chromatography of the residue
on basic alumina gave photoproducts 6.
was removed in vacuo to provide product oils, which were
chromatographed using 1:1 hexane/ether.
N-(Eth oxyca r bon yl)-2-a za bicyclo[2.2.0]h ex-5-en e (6a ).
Irradiation of 1,2-dihydropyridine 5a (500 mg, 3.3 mmol) for
24 h afforded 252 mg (50%) of photoproduct 6a (Rf ) 0.56, 1:1
hexane/ether): 1H NMR δ 1.23 (t, J ) 7.2 Hz, 3H), 3.39 (m,
1H), 3.48 (ddd, J ) 8.7, 2.4, 1.5 Hz, 1H), 3.94 (dd, J ) 8.7, 7.2
Hz, 1H), 4.11 (q, J ) 7.2 Hz, 2H), 4.81 (m, 1H), 6.49 (m, 2H);
13C NMR δ 14.5, 38,3, 49.6, 60.6, 65.5, 140.6, 142.9, 157.2;
HRMS m/z 153.0797, calcd for C8H11NO2, 153.0790.
P r ep a r a tion of N-(Eth oxyca r bon yl)-5-en d o-6-exo-d i-
b r om o-4-m et h yl-2-a za b icyclo[2.2.0]h exa n e (8b ) a n d N-
(Eth oxyca r bon yl)-5-a n ti-6-a n ti-d ibr om o-4-m eth yl-2-a za -
bicyclo[2.1.1]h exan e (9b). From 4-methyl-2-azabicyclo[2.2.0]-
hexene 6b (59 mg, 0.35 mmol) and bromine (56 mg, 0.35 mmol)
in CH2Cl2 (10 mL) there were obtained according to the general
procedure 22 mg (19%) of unrearranged dibromide 8b at Rf )
0.63 and 61 mg (54%) of rearranged dibromide 9b at Rf ) 0.55.
The dibromide 8b: 1H NMR δ 1.27 (t, J ) 7.2 Hz, 3H), 1.45
(s, 3H), 3.92 (d, J ) 9.3 Hz, 1H), 4.17 (q, J ) 7.2 Hz, 2H), 4.37
(d, J ) 5.1 Hz, 1H), 4.45 (s, 1H), 4.52 (d, J ) 9.3 Hz, 1H), 4.57
(1H, d, J ) 5.1 Hz, 1H); 13C NMR δ 14.6, 20.8, 44.1, 48.3, 57.6,
58.4, 62.2, 70.3, 155.6; HRMS m/z 325.9378, 327.9407, 329.9334,
calcd for C9H1479/79, 79/81, 81/81Br2NO2, 325.9391, 327.9371,
329.9350. The rearranged dibromide 9b: 1H NMR δ 1.27 (t,
J ) 7.2 Hz, 3H), 1.34 (s, 3H), 3.46 (s, 2H), 4.04 (s, 1H), 4.17
(q, J ) 7.2 Hz, 2H), 4.51 (s, 1H); 13C NMR δ 12.3, 14.6, 29.6,
54.5, 56.0, 61.8, 64.1, 155.0; HRMS m/z 325.9396, 327.9366,
329.9282, calcd for C9H1479/79, 79/81, 81/81Br2NO2, (M + H),
325.9391, 327.9370, 329.9350.
P r ep a r a tion of N-(Eth oxyca r bon yl)-5-a n ti-6-a n ti-d i-
br om o-3-m eth yl-2-azabicyclo-[2.1.1]h exan e (9c). From 3-en-
do-methyl-2-azabicyclo[2.2.0]hexene 6c (300 mg, 1.8 mmol)
and bromine (287 mg, 1.8 mmol) in CH2Cl2 (10 mL) there was
obtained according to the general procedure 580 mg (99%) of
rearranged dibromide 9c (Rf ) 0.49): 1H NMR δ 1.26 (t, J )
7.2 Hz, 3H), 1.41 (d, J ) 6.6 Hz, 3H), 2.92 (d, J ) 7.2 Hz, 1H),
4.10 (d, J ) 7.5 Hz, 1H), 4.15 (q, J ) 7.2 Hz, 2H), 4.29 (d, J )
7.5 Hz, 1H), 4.55 (d, J ) 7.2 Hz, 1H); 13C NMR δ 14.5, 18.0,
48.3, 52.4, 54.8, 58.1, 61.7, 66.8, 155.3; HRMS (EI) m/z
246.0124, 248.0149, calcd for C9H1379/81BrNO2 - Br, 246.0129,
248.0109.
N-(Eth oxyca r bon yl)-4-m eth yl-2-a za bicyclo[2.2.0]h ex-
5-en e (6b). According to Fowler’s procedure 3-picoline (30 g,
0.32 mmol) afforded 17.0 g (32%) of crude clear liquid 3-methyl-
1,2-dihydropyridine 5b (Rf ) 0.47, 4:1 hexane/ether): 1H NMR
δ 1.20 (t, J ) 7.2 Hz, 3H), 1.61 (s, 3H), 4.11 (m, 4H), 4.99 (m,
1H), 5.48 (m, 1H), 6.54 (m, 1H). Upon irradiation of crude 5b
(500 mg, 3.0 mmol), there was afforded 105 mg (16%) of
photoproduct 6b (Rf ) 0.51, 1:1 hexane/ether): 1H NMR δ 1.26
(t, J ) 7.2 Hz, 3H), 1.37 (s, 3H), 3.59 (d, J ) 8.4, 1.2 Hz, 1H),
3.66 (d, J ) 8.4 Hz, 1H), 4.13 (q, J ) 7.2 Hz, 2H), 4.48 (d, J )
3.3, 1.2 Hz, 1H), 6.44 (d, J ) 2.4 Hz, 1H), 6.49 (dd, J ) 3.3,
2.4 Hz, 1H); 13C NMR δ 14.6, 17.7, 46.5, 55.2, 60.6, 68.3, 137.6,
146.2, 157.1; HRMS m/z 167.0934, calcd for C9H13NO2, 167.0946.
N-(Eth oxyca r bon yl)-3-m eth yl-2-a za bicyclo[2.2.0]h ex-
5-en e (6c). Irradiation of 2-methyl-1,2-dihydropyridine 5c (500
mg, 3.0 mmol) afforded 105 mg (21%) of photoproduct 6c
(Rf ) 0.47, 1:1 hexane/ether): 1H NMR δ 1.25 (t, J ) 7.2 Hz,
3H), 1.33 (d, J ) 6.3 Hz, 3H), 3.51 (m, J ) 7.5, 7.5, 3.0, 1.8
Hz, 1H), 4.12 (q, J ) 7.2 Hz, 2H), 4.28 (qd, J ) 7.5, 6.3 Hz,
1H), 4.74 (dd, J ) 3.3, 3.0 Hz, 1H), 6.38 (dd, J ) 3.3, 2.4 Hz,
1H), 6.58 (dd, J ) 2.4, 1.8 Hz, 1H); 13C NMR δ 14.6, 16.0, 43.0,
56.1, 60.0, 63.0, 140.0, 142.7, 155.8; HRMS m/z 167.0945, calcd
for C9H13NO2, 167.0946.
N-(E t h oxyca r b on yl)-3-en d o-4-d im et h yl-2-a za b icyclo-
[2.2.0]h ex-5-en e (6d ). Irradiation of 2,3-dimethyl-1,2-dihy-
dropyridine 5d (500 mg, 2.76 mmol) afforded 65 mg (13%) of
photoproduct 6d (Rf ) 0.51, 1:1 hexane/ether): 1H NMR δ 1.26
(t, J ) 7.2 Hz, 3H), 1.29 (d, J ) 6.6 Hz, 3H), 1.34 (s, 3H), 3.94
(q, J ) 6.6 Hz, 1H), 4.13 (q, J ) 7.2 Hz, 2H), 4.39 (d, J ) 3.6
Hz, 1H), 6.36 (dd, J ) 3.6, 2.4 Hz, 1H), 6.53 (d, J ) 2.4 Hz,
1H); 13C NMR δ 14.7, 15.8, 17.7, 50.5, 60.4, 61.9, 65.6, 139.6,
144.0, CO lost; HRMS m/z 181.1104, calcd for C10H15NO2,
181.1105.
N-(Eth oxyca r bon yl)-3-en d o-p h en yl-2-a za bicyclo[2.2.0]-
h ex-5-en e (6e). Irradiation of crude 2-phenyl-1,2-dihydropyr-
idine 6e (8.79 g, 37 mmol)2c for 21 h afforded after chroma-
tography 941 mg (11%) of photoproduct 6e (Rf ) 0.43, 2:1
ether/hexane): 1H NMR δ 1.21 (t, J ) 7.0 Hz, 3H), 3.81 (d,
J ) 7.4 Hz, 1H), 4.10 (br, 2H), 4.98 (s, 1H), 5.26 (d, J ) 7.8
Hz, 1H), 6.00 (br, 1H), 6.59 (br, 1H), 7.29 (m, 5H); 13C NMR δ
44,6, 60.8, 63.1, 126.1, 127.1, 127.8, 128.5, 140.7, 141.9, 155.9;
HRMS m/z 230.1177, calcd for C14H16NO2 (M + H), 230.1181.
N-(Eth oxyca r bon yl)-5-m eth yl-2-a za bicyclo[2.2.0]h ex-
5-en e (6f). According to the general procedure, 4-picoline (30
g, 0.33 mmol) afforded 18.1 g (33%) of clear liquid 4-methyl-
1,2-dihydropyridine 5e (Rf ) 0.47, 4:1 hexane/ether): 1H NMR
δ 1.22 (t, J ) 7.2 Hz, 3H), 1.62 (s, 3H), 4.13 (s, 2H), 4.22 (s,
2H), 4.92 (m, 1H), 5.11 (m, 1H), 6.64 (m, 1H). Upon irradiation
of crude 5c (500 mg, 3.0 mmol), there was afforded 125 mg
(25%) of photoproduct 6c (Rf ) 0.40, 1:1 hexane/ether): 1H
NMR δ 1.27 (t, J ) 7.2 Hz, 3H), 1.84 (s, 3H), 3.22 (m, 1H),
3.42 (dd, J ) 8.7, 2.4 Hz, 1H), 3.85 (dd, J ) 8.7, 7.2 Hz, 1H),
4.08 (q, J ) 7.2 Hz, 2H), 4.63 (m, 1H), 6.16 (s, 1H); 13C NMR
δ 14.3, 14.9, 39.5, 48.7, 60.4, 61.8, 133.0, 153.5, 157.3; HRMS
m/z 167.0943, calcd for C9H13NO2, 167.0946.
Gen er a l P r oced u r e for Ad d ition of Br om in e to N-(Eth -
oxyca r bon yl)-2-a za bicyclo[2.2.0]h exen es 6b -f. The previ-
ously described procedure was followed1 in which a solution
of bromine (1 mmol) in CH2Cl2 (3 mL) was added dropwise to
a cold (-5 °C) solution of the alkene 6 (1 mmol) in CH2Cl2 (10
mL) under argon, and the resulting solution was stirred for 2
h and then allowed to come to room temperature and stirred
for an additional 16 h. The solution was diluted with ether
(25 mL), washed with 10% aqueous sodium bisulfite (10 mL)
and water (10 mL), dried over MgSO4, and filtered, and solvent
P r ep a r a tion of N-(Eth oxyca r bon yl)-5-a n ti-6-a n ti-d i-
br om o-3,4-d im eth yl-2-a za bicyclo[2.1.1]h exa n e (9d ). From
3-endo-4-dimethyl-2-azabicyclo[2.2.0]hexene 6d (100 mg, 0.55
mmol) and bromine (88 mg, 0.55 mmol) in CH2Cl2 (10 mL)
there was obtained according to the general procedure 168 mg
(89%) of rearranged dibromide 9d (Rf ) 0.66): 1H NMR δ 1.24
(s, 3H), 1.28 (t, J ) 7.2 Hz, 3H), 1.35 (d, J ) 6.3 Hz, 3H), 3.79
(q, J ) 6.3 Hz, 3H), 3.97 (d, J ) 7.5 Hz, 1H), 4.18 (q, J ) 7.2
Hz, 2H), 4.23 (d, J ) 7.5 Hz, 1H), 4.55 (s, 1H); 13C NMR δ
11.5, 14.5, 15.8, 52.8, 55.7, 57.5, 60.6, 61.6, 64.1, 155.4; HRMS
(EI) m/z 260.0284, 262.0251, calcd for C10H1579/81BrNO2 - Br,
260.0286, 262.0266.
P r ep a r a tion of N-(Eth oxyca r bon yl)-5-a n ti-6-a n ti-d i-
br om o-3-ph en yl-2-azabicyclo[2.1.1]h exan e (9e). From 3-en-
do-phenyl-2-azabicyclo[2.2.0]hexene 6e (114 mg, 0.50 mmol)
and bromine (80 mg, 0.50 mmol) in CH2Cl2 (13 mL) there was
obtained according to the general procedure 165 mg (85%) of
rearranged dibromide 9e (Rf ) 0.55, 2:1 ether/hexane): 1H
NMR δ 1.28 (br, 3H), 3.30 (d, J ) 7.5 Hz, 1H), 4.23 (m, 4H),
4.76 (d, J ) 7.5 Hz, 1H), 5.17 (s, 1H), 7.44 (m, 5H); 13C NMR
δ 1.5, 47.1, 51.5, 55.4, 62.2, 64.4, 66.9, 126.2, 127.8, 128.7,
137.4, 156.3; mp 187.5-189.0 °C (ether). HRMS (FAB) m/z
387.9572, calcd for C14H1679/79Br2NO2 (M + H), 387.9548.
P r ep a r a tion of N-(Eth oxyca r bon yl)-5-en d o-6-exo-d i-
br om o-5-exo-m eth yl-2-a za bicyclo[2.2.0]h exa n e (8f) a n d
N-(Eth oxyca r bon yl)-6-exo-br om o-5-m eth ylen e-2-a za bicy-
clo[2.2.0]h exan e (10). (Meth od A). From 5-methyl-azabicyclo-
[2.2.0]hexene 6f (221 mg, 1.32 mmol) and bromine (211 mg,
1.32 mmol) in CH2Cl2 (25 mL) there was obtained according
to the general procedure 172 mg of an oil with a minor
component 10 inseparable by column chromatography. Reflux
of the mixture in benzene (3 h) decomposed the minor
component, and chromatography gave 82 mg (43%) of unre-
arranged dibromide 8f at Rf ) 0.50: 1H NMR (70 °C) δ 1.27
(t, J ) 7.2 Hz, 3H), 2.00 (s, 3H), 3.07 (ddd, J ) 7.2, 4.5, 2.7
Hz, 1H), 4.15 (q, J ) 7.2 Hz, 2H), 4.28 (dd, J ) 9.6, 7.2 Hz,
1H), 4.46 (dd, J ) 9.6, 2.7 Hz, 1H), 4.54 (d, J ) 4.5 Hz, 1H),
4.93 (s, 1H); an NOE of 11% was observed for the peak at δ
3.07 (H4) upon irradiation of the methyl group at δ 3.00; 13C
NMR δ 14.6, 32.3, 44.6, 54.8, 55.6, 59.6, 61.5, 66.2, 155.3;
79/79,
HRMS m/z 325.9379, 327.9370, 329.9359, calcd for C9H14